{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:20:42Z","timestamp":1775607642191,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Clinical Research (ALFGBG)"},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"wedish Society of the Neurologically Disabled"},{"name":"Edit Jacobson Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1111\/ane.12927","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T22:06:10Z","timestamp":1523052370000},"page":"143-150","source":"Crossref","is-referenced-by-count":37,"title":["Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barr\u00e9 syndrome: A pilot study"],"prefix":"10.1155","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2036-4007","authenticated-orcid":false,"given":"M.","family":"Axelsson","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sj\u00f6gren","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9089-0451","authenticated-orcid":false,"given":"O.","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Blennow","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; The University of Gothenburg; M\u00f6lndal Sweden"},{"name":"Clinical Neurochemistry Laboratory; Sahlgrenska University Hospital; M\u00f6lndal Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; The University of Gothenburg; M\u00f6lndal Sweden"},{"name":"Clinical Neurochemistry Laboratory; Sahlgrenska University Hospital; M\u00f6lndal Sweden"},{"name":"Department of Molecular Neuroscience; UCL Institute of Neurology; London UK"},{"name":"UK Dementia Research Institute; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lycke","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"10.1111\/ane.12927-BIB0001|ane12927-cit-0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1468-1331.2000.00006.x","article-title":"Incidence of Guillain-Barre syndrome in Sweden 1996","volume":"7","author":"Cheng","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.12927-BIB0002|ane12927-cit-0002","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jnnp.62.5.447","article-title":"Epidemiological features of Guillain-Barre syndrome in Sweden, 1978-93","volume":"62","author":"Jiang","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12927-BIB0003|ane12927-cit-0003","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/ane.12927-BIB0004|ane12927-cit-0004","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1111\/ane.12927-BIB0005|ane12927-cit-0005","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12927-BIB0006|ane12927-cit-0006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000052111","article-title":"Diagnostic and classification criteria for the Guillain-Barre syndrome","volume":"45","author":"Van der Meche","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1111\/ane.12927-BIB0007|ane12927-cit-0007","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barre syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1111\/ane.12927-BIB0008|ane12927-cit-0008","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome","volume":"7","author":"Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.12927-BIB0009|ane12927-cit-0009","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barre syndrome","volume":"6","author":"Koningsveld","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.12927-BIB0010|ane12927-cit-0010","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/ane.12927-BIB0011|ane12927-cit-0011","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/ane.12786","article-title":"A rating scale for the severity of Guillain-Barre syndrome","volume":"136","author":"Guan","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12927-BIB0012|ane12927-cit-0012","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/mus.23752","article-title":"Serial cerebrospinal fluid neurofilament heavy chain levels in severe Guillain-Barre syndrome","volume":"48","author":"Dujmovic","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1111\/ane.12927-BIB0013|ane12927-cit-0013","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mus.21239","article-title":"CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barre syndrome","volume":"40","author":"Petzold","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1111\/ane.12927-BIB0014|ane12927-cit-0014","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1212\/01.wnl.0000237334.69665.92","article-title":"CSF neurofilament levels: a potential prognostic marker in Guillain-Barre syndrome","volume":"67","author":"Petzold","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/ane.12927-BIB0015|ane12927-cit-0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365517709091496","article-title":"Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values","volume":"37","author":"Tibbling","year":"1977","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/ane.12927-BIB0016|ane12927-cit-0016","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000115747","article-title":"Isoelectric focusing followed by silver staining. A suitable method for routine investigation of cerebrospinal fluid proteins","volume":"23","author":"Wikkelso","year":"1984","journal-title":"Eur Neurol"},{"key":"10.1111\/ane.12927-BIB0017|ane12927-cit-0017","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"Rosengren","year":"1996","journal-title":"J Neurochem"},{"key":"10.1111\/ane.12927-BIB0018|ane12927-cit-0018","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-0270(94)90011-6","article-title":"A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults","volume":"51","author":"Rosengren","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1111\/ane.12927-BIB0019|ane12927-cit-0019","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000142988.49341.D1","article-title":"Neurofilament and glial fibrillary acidic protein in multiple sclerosis","volume":"63","author":"Norgren","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/ane.12927-BIB0020|ane12927-cit-0020","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1111\/ane.12927-BIB0021|ane12927-cit-0021","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12927-BIB0022|ane12927-cit-0022","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1111\/ane.12927-BIB0023|ane12927-cit-0023","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/mus.880120602","article-title":"Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features","volume":"12","author":"Albers","year":"1989","journal-title":"Muscle Nerve"},{"key":"10.1111\/ane.12927-BIB0024|ane12927-cit-0024","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1111\/ane.12927-BIB0025|ane12927-cit-0025","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"10.1111\/ane.12927-BIB0026|ane12927-cit-0026","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mus.20983","article-title":"Glial fibrillary acidic protein: a marker of axonal Guillain-Barre syndrome and outcome","volume":"38","author":"Notturno","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1111\/ane.12927-BIB0027|ane12927-cit-0027","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/mus.21283","article-title":"Glial fibrillary acidic protein in Guillain-Barre syndrome: methodological issues","volume":"39","author":"Petzold","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1111\/ane.12927-BIB0028|ane12927-cit-0028","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0022-510X(91)90066-G","article-title":"Schwann cell GFAP expression increases in axonal neuropathies","volume":"102","author":"Mancardi","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1111\/ane.12927-BIB0029|ane12927-cit-0029","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/(SICI)1098-1136(199608)17:4<294::AID-GLIA4>3.0.CO;2-#","article-title":"Beta 4 integrin and other Schwann cell markers in axonal neuropathy","volume":"17","author":"Quattrini","year":"1996","journal-title":"Glia"},{"key":"10.1111\/ane.12927-BIB0030|ane12927-cit-0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2004.09.021","article-title":"Impairment in Guillain-Barre syndrome during the first 2\u00a0years after onset: a prospective study","volume":"227","author":"Forsberg","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1111\/ane.12927-BIB0031|ane12927-cit-0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2016.06.030","article-title":"Neurofilament light: a dynamic cross-disease fluid biomarker for neurodegeneration","volume":"91","author":"Zetterberg","year":"2016","journal-title":"Neuron"},{"key":"10.1111\/ane.12927-BIB0032|ane12927-cit-0032","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain-Barre syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12927","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12927\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:51:24Z","timestamp":1671540684000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12927","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,6]]}}}